Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epratuzumab in Japanese SLE patients
NCT01449071Phase 2Completed
- Sponsor
- UCB
- Start
- Oct 2011
- Primary completion
- Mar 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of epratuzumab in systemic lupus erythematosus (SLE), sponsored by UCB. Started Oct 2011; status: completed.
02
Drugs
epratuzumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01449071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01449071.